Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioceres Crop Solutions (BIOX) Current Deferred Revenue (2017 - 2022)

Bioceres Crop Solutions' Current Deferred Revenue history spans 4 years, with the latest figure at $360000.0 for Q4 2021.

  • For Q4 2021, Current Deferred Revenue changed N/A year-over-year to $360000.0; the TTM value through Dec 2021 reached $360000.0, changed N/A, while the annual FY2020 figure was $2.9 million, 166.69% up from the prior year.
  • Current Deferred Revenue for Q4 2021 was $360000.0 at Bioceres Crop Solutions, down from $2.9 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $2.9 million in Q2 2020 and bottomed at $360000.0 in Q4 2021.
  • The 4-year median for Current Deferred Revenue is $1.0 million (2018), against an average of $1.3 million.
  • The largest annual shift saw Current Deferred Revenue increased 6.67% in 2019 before it soared 166.69% in 2020.
  • A 4-year view of Current Deferred Revenue shows it stood at $1.0 million in 2018, then grew by 6.67% to $1.1 million in 2019, then skyrocketed by 166.69% to $2.9 million in 2020, then tumbled by 87.44% to $360000.0 in 2021.
  • Per Business Quant, the three most recent readings for BIOX's Current Deferred Revenue are $360000.0 (Q4 2021), $2.9 million (Q2 2020), and $1.1 million (Q2 2019).